A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.

Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.

Received in the Senate.

Received in the Senate.

Referred to the House Committee on Energy and Commerce.

Referred to the House Committee on Energy and Commerce.